Hakuhodo DY Holdings Inc (TYO:2433)

Marinus Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	922,775	953,316	946,776	991,137	895,080	1,297,947
Revenue Growth (YoY)	-2.42%	0.69%	-4.48%	10.73%	-31.04%	-11.48%
Cost of Revenue	526,415	553,717	552,601	587,572	507,986	984,729
Gross Profit	396,360	399,599	394,175	403,565	387,094	313,218
Selling, General & Admin	348,158	349,305	347,168	335,240	305,466	260,420
Operating Expenses	360,459	362,017	359,886	348,154	315,450	268,184
Operating Income	35,901	37,582	34,289	55,411	71,644	45,034
Interest Expense	-1,307	-1,296	-1,139	-670	-665	-483
Interest & Investment Income	3,766	4,023	2,763	2,657	2,579	3,451
Earnings From Equity Investments	-1,449	-1,346	-2,070	-194	2,607	670
Currency Exchange Gain (Loss)	-2,248	-624	1,358	944	551	-4
Other Non Operating Income (Expenses)	4,228	4,320	2,614	2,230	-976	924
EBT Excluding Unusual Items	38,891	42,659	37,815	60,378	75,740	49,592
Gain (Loss) on Sale of Investments	1,101	1,160	21,077	1,900	23,282	13,676
Gain (Loss) on Sale of Assets	-	-	-	-	-	27
Asset Writedown	-6,455	-6,244	-2,109	-1,491	-325	-457
Other Unusual Items	-5,341	-6,235	-5,449	-1,577	-3,989	-9,170
Pretax Income	28,196	31,340	51,334	59,210	94,708	53,668
Income Tax Expense	18,797	18,958	24,542	25,724	35,846	24,548
Earnings From Continuing Operations	9,399	12,382	26,792	33,486	58,862	29,120
Minority Interest in Earnings	-764	-1,614	-1,869	-2,476	-3,683	-2,641
Net Income	8,635	10,768	24,923	31,010	55,179	26,479
Net Income to Common	8,635	10,768	24,923	31,010	55,179	26,479
Net Income Growth	-66.83%	-56.79%	-19.63%	-43.80%	108.39%	-41.02%
Shares Outstanding (Basic)	367	367	367	373	374	373
Shares Outstanding (Diluted)	367	367	367	373	374	373
Shares Change (YoY)	-0.03%	0.02%	-1.52%	-0.20%	0.06%	0.06%
EPS (Basic)	23.51	29.32	67.87	83.16	147.70	70.91
EPS (Diluted)	23.50	29.31	67.86	83.16	147.68	70.90
EPS Growth	-66.83%	-56.81%	-18.40%	-43.69%	108.28%	-41.05%
Free Cash Flow	-	78,567	3,145	31,031	15,815	31,448
Free Cash Flow Per Share	-	213.91	8.56	83.22	42.33	84.22
Dividend Per Share	32.000	32.000	32.000	32.000	32.000	30.000
Dividend Growth	-	-	-	-	6.67%	-
Gross Margin	42.95%	41.92%	41.63%	40.72%	43.25%	24.13%
Operating Margin	3.89%	3.94%	3.62%	5.59%	8.00%	3.47%
Profit Margin	0.94%	1.13%	2.63%	3.13%	6.17%	2.04%
Free Cash Flow Margin	-	8.24%	0.33%	3.13%	1.77%	2.42%
EBITDA	62,356	63,932	60,218	79,953	90,982	60,382
EBITDA Margin	6.76%	6.71%	6.36%	8.07%	10.17%	4.65%
D&A For EBITDA	26,455	26,350	25,929	24,542	19,338	15,348
EBIT	35,901	37,582	34,289	55,411	71,644	45,034
EBIT Margin	3.89%	3.94%	3.62%	5.59%	8.00%	3.47%
Effective Tax Rate	66.66%	60.49%	47.81%	43.45%	37.85%	45.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.